(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AKTIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

AKTIS

ST13

US500000090622804

Class

42

Filing

90622804

Registration

8355795

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

07/21/2026

Classification

Registered

Trademark type

Word

Nice classes

42

Filing date

04/04/2021

Registration date

07/21/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/21/2026

Last transaction

07/21/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2024-05-00

First use in commerce

2024-05-00

Drawing code

4

Owner type

03

Owner location

Cambridge, MA, US

Examiner

LE, KHANH M

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

HotKnot Therapeutics, Inc.

Representatives

Vincent J. Badolato BROWN RUDNICK LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing medical research and scientific research information in the field of radio pharmacological oncology via the Internet; Providing medical and scientific research information in the field of radio pharmacology clinical trials; Providing medical and scientific research information in the field of radiopharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of radiopharmaceuticals and genetics; Scientific investigations for medical purposes in the field of radiopharmacology; Scientific research and development in the field of radiopharmacology

Publications

History of USPTO decisions and trademark events.

54 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/21/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/21/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/29/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/29/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/09/2026

IUAF

USE AMENDMENT FILED

05/26/2026

EISU

TEAS STATEMENT OF USE RECEIVED

05/26/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/03/2025

EX5G

SOU EXTENSION 5 GRANTED

12/03/2025

EEXT

SOU TEAS EXTENSION RECEIVED

11/14/2025

EXT5

SOU EXTENSION 5 FILED

11/13/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/02/2025

EX4G

SOU EXTENSION 4 GRANTED

05/02/2025

EXT4

SOU EXTENSION 4 FILED

05/02/2025

EEXT

SOU TEAS EXTENSION RECEIVED

05/01/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

03/25/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/25/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/25/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/25/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/11/2024

EX3G

SOU EXTENSION 3 GRANTED

10/11/2024

EXT3

SOU EXTENSION 3 FILED

10/11/2024

EEXT

SOU TEAS EXTENSION RECEIVED

10/11/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/07/2024

EX2G

SOU EXTENSION 2 GRANTED

05/06/2024

EXT2

SOU EXTENSION 2 FILED

05/06/2024

EEXT

SOU TEAS EXTENSION RECEIVED

05/06/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/01/2024

EX1G

SOU EXTENSION 1 GRANTED

02/29/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/28/2024

NREV

NOTICE OF REVIVAL - E-MAILED

01/05/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

01/05/2024

PETG

PETITION TO REVIVE-GRANTED

01/05/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

01/05/2024

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

12/26/2023

ABN6

ABANDONMENT - NO USE STATEMENT FILED

12/25/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/30/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/30/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/30/2023

EXT1

SOU EXTENSION 1 FILED

11/24/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/23/2023

TMBN

TTAB RELEASE CASE TO TRADEMARKS

04/11/2023

OP.T

OPPOSITION TERMINATED NO. 999999

04/11/2023

OP.D

OPPOSITION DISMISSED NO. 999999

04/11/2023

OP.I

OPPOSITION INSTITUTED NO. 999999

02/28/2022

DOCK

ASSIGNED TO EXAMINER

01/03/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/30/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/02/2021

PUBO

PUBLISHED FOR OPPOSITION

11/02/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/13/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/26/2021

DOCK

ASSIGNED TO EXAMINER

09/26/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/12/2021

NWAP

NEW APPLICATION ENTERED

04/07/2021

Continuous trademark protection

Get notified about every new filing that threatens AKTIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.